The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utility of circulating tumor DNA (ctDNA) in the management of appendiceal adenocarcinoma (AA).
 
Mohammad A. Zeineddine
No Relationships to Disclose
 
Fadl A. Zeineddine
No Relationships to Disclose
 
Abdelrahman M.G. Yousef
No Relationships to Disclose
 
Julia Dansby
No Relationships to Disclose
 
Michael White
No Relationships to Disclose
 
Michael J. Overman
Consulting or Advisory Role - 3D Medicines; Array BioPharma; Bristol-Myers Squibb; Eisai; Gritstone Bio; Janssen; Janssen; MedImmune; Merck; Novartis; Pfizer; Pfizer; Promega; Roche/Genentech; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Timothy E. Newhook
No Relationships to Disclose
 
Arvind Dasari
Consulting or Advisory Role - Crinetics Pharmaceuticals; Novartis; Personalis; Voluntis
Research Funding - Eisai; Guardant Health; Hutchison MediPharma; Merck
 
Keith F. Fournier
No Relationships to Disclose
 
Kanwal Pratap Singh Raghav
Consulting or Advisory Role - AstraZeneca; Bayer; Daiichi Sankyo; Eisai; Seagen
Speakers' Bureau - Bayer
Research Funding - Bayer (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Guardant Health (Inst); HiberCell (Inst); Merck Serono (Inst); Roche/Genentech (Inst)
 
Abhineet Uppal
No Relationships to Disclose
 
John Paul Y.C. Shen
Stock and Other Ownership Interests - Agios; Syndax; Syndax
Consulting or Advisory Role - Engine Biosciences
Research Funding - Celsius Therapeutics; Celsius Therapeutics